We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





Beckman Coulter Exhibits New Lab Solutions in Dubai

By LabMedica International staff writers
Posted on 08 Feb 2017
Print article
Image: The DxN molecular diagnostics system (Photo courtesy of Beckman Coulter).
Image: The DxN molecular diagnostics system (Photo courtesy of Beckman Coulter).
Beckman Coulter, Inc., an international leader in developing clinical diagnostic products and solutions, exhibited its laboratory solutions, including its DxN VERIS molecular diagnostics system and DxH 500 hematology system, at MEDLAB 2017.

The company’s DxN VERIS molecular diagnostics system aims to revolutionize laboratory workflow by delivering greater productivity and increased flexibility to laboratories, ensuring that results are available to physicians as quickly as possible, for faster clinical decision-making and positively impacting the patient pathway.

Beckman Coulter’s DxH 500 hematology system is the first of a new series of advanced hematology analyzers specifically designed for laboratories with low-volume hematology workloads. With its small sample volume requirements, intuitive software and low reagent consumption, the advanced 5-part differential system aims to simplify the workload in a low-volume lab.

Also on display at the 4-day event held from February 6-9, 2017, in Dubai, UAE, was Beckman Coulter’s DxH Connected Workcells solution for in vitro diagnostic use. In addition to reducing manual work with accurate first-pass results and processing specimens faster with customizable workflow solutions for labs, it delivers reliable results from difficult specimens and also simplifies autovalidation with comprehensive data management.

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Coagulation Analyzer
CS-2400
New
Auto Clinical Chemistry Analyzer
cobas c 703

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.